Dr. Matthew T. Whitehurst, MD

  • Fredericksburg, VA
  • Medical oncologist
NPI1457586208PAC ID9739333436
Medicare services, 2024
239,914
Medicare patients, 2024
1,412
Part D claims, 2024
1,223
Publications
1
MIPS score, 2024
86
Practice address
4501 Empire Ct, Fredericksburg, VA 22408
Practice phone
Call (540) 371-0079
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Hematology-Oncology Associates of Fredericksburg, Inc.

Fredericksburg, Virginia

See all 10 affiliations

Find Dr. Whitehurst's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew T. Whitehurst is a medical oncologist in Fredericksburg, Virginia

Dr. Whitehurst practices at Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia.

Dr. Whitehurst's NPI, 1457586208, was assigned on May 22, 2009. Dr. Whitehurst graduated from University of Maryland School of Medicine in 2015. Dr. Whitehurst holds Virginia license 0101257665.

NPI and contact details
Medicare PAC ID
9739333436
NPI enumeration date
May 22, 2009
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(540) 371-0079
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew T. Whitehurst practices at Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia

Dr. Whitehurst's primary practice is Hematology-Oncology Associates of Fredericksburg, Inc., at 4501 Empire Ct, Fredericksburg, VA 22408 in Spotsylvania County. The practice phone is (540) 371-0079.

  • Hematology-Oncology Associates of Fredericksburg, Inc.
    4501 Empire Ct, Fredericksburg, VA 22408 · Spotsylvania CountyPhone(540) 371-0079

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Matthew T. Whitehurst is affiliated with 8 sites of care and 2 medical groups

Dr. Whitehurst's primary practice is Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia. Dr. Whitehurst is also affiliated with Mary Washington Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Whitehurst to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

See all 10 affiliations for Dr. Whitehurst

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Matthew T. Whitehurst's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Whitehurst practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Hematology-Oncology Associates of Fredericksburg, Inc.Available with a free account
+7 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Whitehurst practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew T. Whitehurst is one of 99 medical oncologists in Virginia

Medical oncology is Dr. Whitehurst's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Whitehurst's licenses on file in 2 states: Virginia and Florida.

Specialties and state licenses

  • Medical oncology, VirginiaPrimaryLicense 0101257665 · taxonomy 207RX0202X
  • Internal medicine, FloridaLicense ME113141 · taxonomy 207R00000X

Medical oncologists near Dr. Whitehurst

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew T. Whitehurst billed Medicare for 239,914 services in 2024

CMS data shows 239,914 Medicare services from Dr. Whitehurst across 85 procedure codes in 2024, for 1,412 Medicare patients. Medicare paid $3,283,977 for them.

Medicare services, 2024239,914
Medicare patients1,412
Paid by Medicare$3.3M
Procedure codes85

Dr. Whitehurst's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 125,6012024: 218,41174%
Lab and pathology
2023: 9,5162024: 10,0526%
Tests and treatments
2023: 3,1942024: 3,77118%
Other services
2023: 6,1782024: 2,90053%
Surgery
2023: 2,1922024: 2,56417%
Office and hospital visits
2023: 2,0512024: 2,2168%

Where Dr. Whitehurst's Medicare services took place, 2024

  • In an office239,755100%
  • In a facility1590%

Dr. Whitehurst compared with the Virginia median for medical oncologists, 2024

  • Dr. Whitehurst
  • Virginia median
Medicare services
239,914vs 566423.9 times
Medicare patients
1,412vs 2226.4 times
Part D claims
954vs 3033.1 times

Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.

Dr. Whitehurst's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Whitehurst

Need commercial claims for Dr. Whitehurst?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Whitehurst and other medical oncologists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew T. Whitehurst treated 1,412 Medicare patients in 2024, average age 75

CMS counts 1,412 Medicare patients who saw Dr. Whitehurst in 2024. The largest group is 65 to 74, with 593 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Whitehurst's median patient age at 69, with 59% women.

Medicare patients, 20241,412
Average age75
Average risk score1.96
Also on Medicaid6%

Dr. Whitehurst's Medicare patients by age, 2024

Dr. Whitehurst's Medicare patients by sex, 2024

  • Women80757%
  • Men60543%

Chronic conditions among Dr. Whitehurst's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis47%
  4. Cancer43%
  5. Ischemic heart disease39%
  6. Diabetes37%
  7. Chronic kidney disease34%
  8. Atrial fibrillation27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Whitehurst's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women59%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew T. Whitehurst wrote 1,223 Medicare Part D claims in 2024

In 2024, Dr. Whitehurst wrote 1,223 Medicare Part D claims for 248 patients. 69% of them were for generic drugs. CMS names the drug for 954 of them, across 29 drugs with 11 or more claims each, at $612,981 in total drug cost. In 2023, CMS named 761 claims across 24 drugs.

Part D claims, 20241,223
Drugs named by CMS29
Total drug cost$612,981
Part D patients248

Dr. Whitehurst's Part D claims by kind of drug, 2024

  • Generic841 claims69%
  • Brand-name382 claims31%

Dr. Whitehurst's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Whitehurst's Part D claims, 2024

  • Opioids4%45 of 1,223 claims
  • Antibiotics3%32 of 1,223 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7612024: 95425%

Drugs named by CMS: 29 in 2024, 24 in 2023.

See all prescribing by Dr. Whitehurst

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew T. Whitehurst scored 86 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Whitehurst for performance year 2024, reported as part of a group. Dr. Whitehurst accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Whitehurst as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Whitehurst's MIPS scores, performance year 2024

  • 86of 100Final score
  • 95of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 49of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Whitehurst by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew T. Whitehurst has 1 publication on record

Dmand AI links 1 paper to Dr. Whitehurst. Dr. Whitehurst's most frequent co-author is Alberto A. Chiappori, MD.

Papers1

Dr. Whitehurst's most frequent co-authors

Recent publications by Dr. Whitehurst

See all 1 publications and co-authors

See who Dr. Whitehurst researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Whitehurst works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew T. Whitehurst received $38,998 in industry payments from 2016 to 2025

CMS Open Payments shows 1,117 general payments to Dr. Whitehurst from 86 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,525.

General payments to Dr. Whitehurst by program year, 2016 to 2025

General payments to Dr. Whitehurst by kind, 2016 to 2025

$39Kin total
  • Food and beverage$17,96946%
  • Consulting fees$16,63043%
  • Speaker and faculty fees$2,5006%
  • Honoraria$1,2003%
  • Other$6992%

Companies that paid Dr. Whitehurst the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Whitehurst

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew T. Whitehurst graduated from University of Maryland School of Medicine

Dr. Whitehurst graduated from University of Maryland School of Medicine in 2015.

  1. Medical schoolUniversity of Maryland School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew T. Whitehurst's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew T. Whitehurst

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew T. Whitehurst's NPI number?

Dr. Matthew T. Whitehurst's NPI number is 1457586208. It was assigned on May 22, 2009, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew T. Whitehurst?

Dr. Matthew T. Whitehurst is a medical oncologist in Fredericksburg, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Matthew T. Whitehurst practice?

Dr. Whitehurst practices at 4501 Empire Ct, Fredericksburg, VA 22408. Dr. Whitehurst's primary practice is Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia. Dmand AI also links Dr. Whitehurst to 3 hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group.

What is Dr. Matthew T. Whitehurst's office phone number?

The practice phone on file for Dr. Whitehurst is (540) 371-0079.

What is Dr. Matthew T. Whitehurst's medical license number?

Dr. Whitehurst holds Virginia license 0101257665, one of the licenses on file in 2 states.

Which states has Dr. Matthew T. Whitehurst been licensed in?

Dmand AI has state licenses on file for Dr. Whitehurst in Virginia and Florida.

Which hospitals is Dr. Matthew T. Whitehurst affiliated with?

Dr. Whitehurst is affiliated with Mary Washington Hospital. Dmand AI links Dr. Whitehurst to 3 more hospitals.

What medical group is Dr. Matthew T. Whitehurst part of?

Dr. Whitehurst is linked to Zangmeister Cancer Center. Dmand AI links Dr. Whitehurst to 1 more medical group.

Does Dr. Matthew T. Whitehurst accept Medicare?

Yes. CMS data shows Dr. Whitehurst billed Medicare for 239,914 services in 2024, and Dr. Whitehurst accepts Medicare assignment.

Does Dr. Matthew T. Whitehurst offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Whitehurst as offering telehealth services.

Show 9 more questionsShow fewer questions

What is Dr. Matthew T. Whitehurst's MIPS score?

Dr. Whitehurst's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.

How many Medicare patients does Dr. Matthew T. Whitehurst see?

CMS counts 1,412 Medicare patients who saw Dr. Whitehurst in 2024, with an average age of 75.

What services does Dr. Matthew T. Whitehurst bill to Medicare?

In 2024, Dr. Whitehurst's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0185) and injected or infused drug (J9271).

Where did Dr. Matthew T. Whitehurst go to medical school?

Dr. Whitehurst graduated from University of Maryland School of Medicine in 2015.

What drugs does Dr. Matthew T. Whitehurst prescribe most?

In 2024 Medicare Part D data, Dr. Whitehurst's most prescribed drugs by claims were Eliquis, Anastrozole and Xarelto.

Has Dr. Matthew T. Whitehurst received payments from drug or device companies?

CMS Open Payments shows $38,998 in general payments to Dr. Whitehurst from 86 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Matthew T. Whitehurst been practicing?

Dr. Whitehurst graduated from medical school in 2015, 11 years ago.

Does Dr. Matthew T. Whitehurst do research?

Dmand AI links 1 publication to Dr. Whitehurst.

Who does Dr. Matthew T. Whitehurst publish with?

Dr. Whitehurst's most frequent co-authors are Alberto A. Chiappori, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)